Deals Rumor Mill: Roche, Invensys, Rio Tinto

By Karlee Weinmann (July 30, 2013, 3:45 PM EDT) -- Alexion Pharmaceuticals Inc. has tapped Goldman Sachs Group Inc. as an adviser after speculation began to swirl that rival Roche Holding AG is plotting a takeover, Bloomberg reported on Tuesday. Roche last week preliminarily approached Alexion, whose blood disease medication clocks in among the most expensive treatments in the world, but the Connecticut-based company rebuffed the interest. But Alexion wants Goldman on its side if Roche ups its bid or shifts its focus to a hostile pursuit. Alexion, whose shares surged on the news, has a market value of more than $20 billion....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!